AIM – aim immunotech inc. (US:NASDAQ)
Stock Stats
News
AIM ImmunoTech Enters Pivotal Value Inflection Phase with Planned Phase 3 Study of Ampligen® in Pancreatic Cancer, Backed by Positive Clinical Signals, Orphan Drug Status, and Global IP
AIM ImmunoTech Provides Routine Update on Annual Filings
AIM ImmunoTech to Participate in Live Virtual Investor Closing Bell Event
AIM ImmunoTech Announces Final Approval of Novel Cancer Therapy Patent in Japan Combining Ampligen with Checkpoint Inhibitors [Yahoo! Finance]
AIM ImmunoTech Announces Final Approval of Novel Cancer Therapy Patent in Japan Combining Ampligen with Checkpoint Inhibitors
Form 8-K AIM ImmunoTech Inc. For: Apr 10
Form 424B5 AIM ImmunoTech Inc.
Form 10-K AIM ImmunoTech Inc. For: Dec 31
Form 4 AIM ImmunoTech Inc. For: Mar 16 Filed by: CHEMEROW DAVID I.
Form 4 AIM ImmunoTech Inc. For: Mar 16 Filed by: Equels Thomas K
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.